Author

Nabil Dorkhom

Observed names: N. Dorkhom, N.V. Dorkhom

Institution: Medscape

Observed institution: Medscape

OpenAlex ID: A5058637124

171P An outcomes summary of the clinical advances curriculum on CDK4 & 6 inhibition in breast cancer

2020 · N. Dorkhom, D. Middleton, et al. · Annals of Oncology · 2

Abstract P4-11-25: Enhancing Care of HR+/HER2- Early Breast Cancer Patient At Risk of Recurrence Through an Expansive Curriculum

2025 · Urvi Patel, Nabil Dorkhom, et al. · Clinical Cancer Research

Enhancing care of patients with HR+/HER2- early breast cancer at high risk of recurrence through an expansive curriculum: Real world outcomes (RWO) from a 6 month analysis.

2025 · Nabil Dorkhom, Urvi Patel, et al. · Journal of Clinical Oncology

Is increase in CME consumption associated with practice change in the real world? An empirical study among oncologists treating breast cancer.

2025 · Katie Lucero, Jordan Schwartz, et al. · Journal of Clinical Oncology

HR+/HER2- early breast cancer with a high risk of recurrence: The impact of online education on clinician knowledge, competence, and confidence in utilization of clinical practice guidelines to enhance patient care.

2024 · Urvi Patel, Nabil Dorkhom, et al. · Journal of Clinical Oncology

Abstract PO2-02-01: Online Virtual Patient Simulation CME Improves Clinical Decision-Making In The Management Of Patients With HR+/HER2- Early Breast Cancer

2024 · Nabil Dorkhom, Urvi Patel, et al. · Cancer Research

EP12.01-13 Educational Impact of A Clinical Advances Curriculum On EGFR Exon 20 Insertion Mutated NSCLC And EGFR TKI-Resistant NSCLC

2023 · N.V. Dorkhom, M. Cannon, et al. · Journal of Thoracic Oncology

HR+/HER2- Breast cancer: The effect of online education on clinician knowledge, competence, and confidence in monitoring, mitigating toxicities, and developing patient-centric plans using a team-based approach.

2023 · Urvi Patel, Nabil Dorkhom, et al. · Journal of Clinical Oncology

128P Impact of an online educational activity on oncologists’ knowledge regarding the latest developments in the treatment of uveal melanoma

2023 · N. Dorkhom, K. Peters, et al. · ESMO Open

27P Outcomes analysis of the effect of an educational activity on the knowledge and confidence of oncologists regarding emerging antibody drug conjugates for the treatment of breast cancer

2022 · N. Dorkhom, D. Grainger, et al. · Annals of Oncology

Breast cancer: Online education’s effect on clinician ability to assess risk of recurrence and understanding the latest data.

2022 · Urvi Patel, Nabil Dorkhom, et al. · Journal of Clinical Oncology

Pb2121: Effect of Educational Activity on the Knowledge of Clinicians Regarding the Latest Clinical Trial Data Investigating Novel Epigenetic Agents for B- and T-cell Lymphomas

2022 · V. Harvey-Jones, S. Koekkoek, et al. · HemaSphere

83P The educational impact of a curriculum for oncologists on the latest developments in the use of CDK4/6 inhibitors in HR+/HER2- early and metastatic breast cancer

2022 · N. Dorkhom, D. Ragoonath-Cameron, et al. · Annals of Oncology

P-76 Effect of educational activity on the knowledge of oncologists regarding the latest clinical trial data investigating immunotherapy combination regimens for the frontline treatment of patients with unresectable HCC

2021 · N. Dorkhom, S. Koekkoek, et al. · Annals of Oncology

P-75 Impact of an educational activity on the knowledge of oncologists regarding the latest clinical trial data on HER2-directed therapies for gastric and colorectal cancer

2021 · N. Dorkhom, D. Cameron, et al. · Annals of Oncology

152P Effect of online continuing education on oncologists' knowledge regarding resistance to EGFR TKIs in NSCLC

2021 · N. Dorkhom, A. Furedy, et al. · Journal of Thoracic Oncology

Abstract PS9-40: Multiple activities improve oncologists' knowledge and competence with CDK4/6 inhibitors in HR+ breast cancer over time

2021 · Kinjal Parikh, Nabil Dorkhom, et al. · Cancer Research

Abstract PS9-64: Impact of online education regarding novel HER2 therapies on translating evidence to practice

2021 · Kinjal Parikh, Nabil Dorkhom, et al. · Cancer Research

Works count: 18

Citation count: 2

H-index: 1

I10-index: